Natera to support Phase 1 trial of Kupando's immunotherapy in advanced skin cancers

Galvanize Therapeutics' new Aliya EX System completes first commercial procedures

Laekna's New Drug Application for LAE002 (afuresertib) accepted by China's NMPA

Labcorp receives FDA approval for melanoma companion diagnostic

BeOne Medicines and Revolution Medicines expand oncology collaboration

ValiRx receives notice of intention to grant Cytolytix European patent

Akeso Advances reports first patient dosed in AK146D1 combined with ivonescimab breast cancer study

BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer

Northwest Biotherapeutics signs MOU for collaboration with SPIMACO in Saudi Arabia

Innovent doses first colorectal cancer patient with IBI363/TAK-928 in combination with bevacizumab

Citius Oncology reports growing LYMPHIR adoption and market access

Obsidian Therapeutics advances Agni-01 study with first patient enrolled in registration-enabling cohort

Summit Therapeutics expands ivonescimab programme into bladder cancer with Phase II/III trial

Lilly secures FDA Breakthrough Therapy designation for olomorasib in pancreatic cancer

Genprex collaborates with Roche Diagnostics on NSCLC biomarker validation